← Back to headlines
Eli Lilly Price Target Raised After FDA Approval for Fundayo
Eli Lilly and Company (LLY) saw its price target raised by analysts following the FDA's approval of its new drug, Fundayo.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Metro Cebu Water District and Manila Water Expand Water Access in Compostela
just now
Latvian Ice Cream Producer Plans New Dessert Factory in Sigulda
4m ago
Latvian Business Developments: Schwenk Plant and Rūjienas Saldējums Expansion
4m ago